NRXP / NRx Pharmaceuticals, Inc. - Propriedade Institucional - Vendedores

NRx Pharmaceuticals, Inc.

Propriedade Institucional e de Fundos - Vendedores

Esta página mostra instituições, fundos e principais acionistas que diminuíram participações ou fecharam suas posições no último período de relatório. Linhas vermelhas indicam posições fechadas. Clique no ícone do link para ver o histórico completo de transações.

Upgrade para desbloquear dados premium.

Data do Arquivo Fonte Investidor Tipo Preço Médio
(Est)
Ações Δ Ações
(%)
Valor
Reportado
(US$1000)
Δ Valor
(%)
Aloc. de Portf.
(%)
2026-01-21 13F Carolina Wealth Advisors, LLC 0 -100.00 0
2026-05-15 13F Morgan Stanley 10,028 -0.01 21 -22.22
2026-05-19 13F/A Anson Funds Management LP 0 -100.00 0 -100.00
2026-05-15 13F Two Sigma Investments, Lp 0 -100.00 0
2026-05-15 13F Point72 Asset Management, L.P. 0 -100.00 0 -100.00
2026-05-15 13F Bank Of America Corp /de/ 0 -100.00 0
2026-02-13 13F Marshall Wace, Llp 0 -100.00 0 -100.00
2026-04-27 13F Commonwealth Equity Services, Llc 0 -100.00 0 -100.00
2026-02-12 13F Renaissance Technologies Llc 0 -100.00 0
2026-05-15 13F National Philanthropic Trust 0 -100.00 0 -100.00
2026-05-15 13F Citadel Advisors Llc Call 24,700 -31.01 53 -46.39
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:B1Q € 3,67
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista